Becton Dickinson jets to Salt Lake City post-Q2 earnings boost

Becton Dickinson's Dassault Falcon 7X, tail number N294X, departed Morristown Municipal Airport in New Jersey on May 11, 2026, at 10:08 a.m. local time, touching down at Salt Lake City International Airport four hours and 31 minutes later. The jet cruised at a maximum altitude of 43,050 feet and speeds up to 449 knots, bridging the continent with corporate efficiency.

The timing aligns with the aftermath of Becton Dickinson's second-quarter fiscal 2026 earnings release on May 7, which reported $4.7 billion in revenue—a 5.2% increase as reported—and raised full-year profit forecasts due to surging demand for drug delivery devices, per a Reuters report that day. Salt Lake City anchors one of the company's largest facilities, in nearby Sandy, Utah, where it produces over 600 million lifesaving IV lines and vascular products annually, as detailed on Becton Dickinson's website. Such visits underscore the quiet machinery behind medical supply chains.

This cross-country hop echoes recent patterns in Becton Dickinson's flight log, including multiple trips to its El Paso, Texas, manufacturing site earlier in May. With recurring jaunts to hubs like Chicago and San Francisco, plus international outposts in London and Tokyo, the company's Falcon 7X logs the unheralded miles of global medtech oversight.